Stocktoria

HeartSciences Inc. HSCS

HeartSciences Inc. statistics & valuation

P / B47.1×
Net margin-201499.5%
FCF margin-170486.2%
Return on capital-1607.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-33592.60% -123384.30% -35511.90% -201499.50% 2022202320242025
Gross margin (%)
45.10% 45.70% 67.30% 56.80% 2022202320242025
Operating margin (%)
-32765.60% -118698.30% -33902.00% -192013.10% 2022202320242025
Return on equity (%)
-2756.10% -90.30% -4272.20% 2022202320242025
Shares outstanding
3.3M 101332 676598 1.1M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-231.10% -193.30% -69.50% -207.60% 2022202320242025
Free cash flow margin (%)
-25367.50% -112463.80% -32981.90% -170486.20% 2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$1.45 -$80.00 -$18.74 -$9.34 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin56.8%67.3%45.7%45.1%
Operating margin-192013.1%-33902.0%-118698.3%-32765.6%
Net margin-201499.5%-35511.9%-123384.3%-33592.6%
FCF margin-170486.2%-32981.9%-112463.8%-25367.5%
Return on assets-207.6%-69.5%-193.3%-231.1%
Return on equity-4272.2%-90.3%-2756.1%79.7%
Current ratio0.594.201.470.56

Computed from company filings · US · as of 2025-04-30. Facts plus Stocktoria's own computed scores — not investment advice.